Search:
Company history
Company founder Dr Eberhard Lampeter
Already in the early 1990s the immunologist and diabetes specialist Dr Eberhard Lampeter recognised while researching in the area of diabetes what potential stem cells have for autoimmune diseases. On the basis of these findings, he developed a routine method for storing the particularly valuable stem cells from the blood of the umbilical cord – and has set standards in doing so.
In 1997 Dr Lampeter founded in Leipzig Germany’s first bank for blood of the umbilical cord for private use: Vita 34. The name has an obliging meaning. Vita is the Latin word for life, the number 34 stands for the surface molecule CD 34, which characterises blood-forming stem cells. Vita 34 thus symbolises the responsibility and the commitment of the company and its employees to the protection of life.
The oldest bank for blood of the umbilical cord in Germany
In the meantime, Vita 34 has become the biggest bank for blood of the umbilical cord in Germany and is consistently expanding this position. The company, which is headed by the recognised pioneer in storing blood of the umbilical cord, Dr Eberhard Lampeter, is characterised by high-quality preparations, innovative processes and methods, qualified specialist staff, strictest security standards and alliances with strong partners.
In order to secure and further expand its position in the recovery, preparation and storage of stem cells in the long term, Vita 34 actively contributes to the development of the growth sector of regenerative medicine. To this end, Vita 34 supports the research initiatives of renowned universities, opinion-making scientists and leading research institutes.
In the meantime, Vita 34 has become the biggest bank for blood of the umbilical cord in Germany and is consistently expanding this position. The company, which is headed by the recognised pioneer in storing blood of the umbilical cord, Dr Eberhard Lampeter, is characterised by high-quality preparations, innovative processes and methods, qualified specialist staff, strictest security standards and alliances with strong partners.
In order to secure and further expand its position in the recovery, preparation and storage of stem cells in the long term, Vita 34 actively contributes to the development of the growth sector of regenerative medicine. To this end, Vita 34 supports the research initiatives of renowned universities, opinion-making scientists and leading research institutes.
Collecting data when preparing blood of the umbilical cord
First successful applications
Although the options to store blood of the umbilical cord have only existed for a couple of years and all owners of a stem cell deposit are still very young, Vita 34 preparations have already helped to save lives.
Although the options to store blood of the umbilical cord have only existed for a couple of years and all owners of a stem cell deposit are still very young, Vita 34 preparations have already helped to save lives.
Company history at a glance
1997- Establishment of Vita 34 GmbH in
- The Free State of Saxony supports the research work of Vita 34 with EUR 720,000
- Conversion of the GmbH into a joint-stock company
- Establishment of VITA 34 International AG
- Unveiling of the world’s first glass stem cell laboratory in Bio City Leipzig
- Presentation of sensational research results regarding stroke treatment at congresses
- The Free State of Saxony supports the research work of Vita 34 with EUR 410,000
- Publication of important research results on heart attack treatment
- Launch of an improved recovery test developed by Vita 34
- StemCare
- First use of a blood of the umbilical cord preparation stored at Vita 34
- Licence as medicinal product from the Paul-Ehrlich Institute
- Secuvita
- As of 27 March, Vita 34 International is listed at the
- First combined storage model: VitaplusSpende
- The Free State of Saxony supports the research work of Vita 34 with some EUR 2,000,000
- 50,000 blood of the umbilical cord preparations stored at Vita 34
- Vita 34 and the research group Diabetes of the Technical University of Munich start a study to examine the use of own blood of the umbilical cord for type 1 diabetes.
- Sorgente Italy
- Izvorna Celica Slovenia becomes a sales partner
- 67,000 blood of the umbilical cord preparations stored at Vita 34
- 70,000 blood of the umbilical cord preparations stored at Vita 34
- The Free State of Saxony and the European Regional Development Funds upport the research work of Vita 34 with EUR 769,000